Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.582
+0.006 (1.08%)
Mar 6, 2026, 9:30 AM EST - Market open
MTNB Employees
Matinas BioPharma Holdings had 3 employees as of December 31, 2024. The number of employees decreased by 29 or -90.63% compared to the previous year.
Employees
3
Change (1Y)
-29
Growth (1Y)
-90.63%
Revenue / Employee
n/a
Profits / Employee
-$5,828,000
Market Cap
3.73M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| HCW Biologics | 36 |
| GeoVax Labs | 17 |
| Genprex | 13 |
| BioRestorative Therapies | 11 |
| Indaptus Therapeutics | 7 |
| Galmed Pharmaceuticals | 6 |
| Oragenics | 5 |
| Acurx Pharmaceuticals | 4 |
MTNB News
- 1 year ago - Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors - GlobeNewsWire
- 1 year ago - Matinas BioPharma Announces Agreement for the Acquisition of Preferred Stock and Appointment of Dr. Robin L. Smith to the Board of Directors - GlobeNewsWire
- 1 year ago - Matinas BioPharma Appoints Evelyn D'An to Board of Directors as Audit Committee Chair - GlobeNewsWire
- 1 year ago - Matinas BioPharma Receives NYSE Noncompliance Notice - GlobeNewsWire
- 1 year ago - Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction - GlobeNewsWire
- 1 year ago - Matinas BioPharma Holdings, Inc. (MTNB) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 1 year ago - Matinas BioPharma to Webcast Conference Call to Discuss Second Quarter 2024 Financial Results and Provide a Business Update on August 14, 2024 - GlobeNewsWire